CNCR vs. HTEC ETF Comparison

Comparison of Loncar Cancer Immunotherapy ETF (CNCR) to Robo Global Healthcare Technology and Innovation ETF (HTEC)
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description

ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$15.80

Average Daily Volume

3,704

Number of Holdings *

67

* may have additional holdings in another (foreign) market
HTEC

Robo Global Healthcare Technology and Innovation ETF

HTEC Description The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the ROBO Global Healthcare Technology and Innovation Index. The fund will normally invest at least 80% of its total assets in securities of the index or in depositary receipts representing securities of the index. The index is designed to measure the performance of companies that have a portion of their business and revenue derived from the field of healthcare technology, and the potential to grow within this space through innovation and market adoption of such companies products and services. It is non-diversified.

Grade (RS Rating)

Last Trade

$29.81

Average Daily Volume

4,753

Number of Holdings *

55

* may have additional holdings in another (foreign) market
Performance
Period CNCR HTEC
30 Days 7.26% 3.60%
60 Days 11.42% 5.01%
90 Days 15.08% 4.45%
12 Months 52.07% 28.07%
2 Overlapping Holdings
Symbol Grade Weight in CNCR Weight in HTEC Overlap
BMY B 1.48% 1.4% 1.4%
REGN F 1.0% 1.15% 1.0%
CNCR Overweight 65 Positions Relative to HTEC
Symbol Grade Weight
GLUE C 2.16%
GNLX D 1.72%
RVMD B 1.69%
EXEL A 1.69%
ELVN B 1.68%
RAPT D 1.62%
KPTI D 1.61%
REPL B 1.55%
IOVA C 1.55%
HCM C 1.54%
MGNX D 1.54%
BMEA F 1.54%
YMAB C 1.54%
ACLX A 1.52%
JANX C 1.49%
CRBU D 1.48%
RPTX D 1.47%
ARVN C 1.46%
DAWN C 1.46%
BPMC C 1.43%
SNDX C 1.42%
IGMS D 1.4%
AURA B 1.39%
MRUS B 1.37%
XNCR C 1.37%
ALLO C 1.34%
ACRV C 1.33%
KYMR B 1.31%
STRO C 1.31%
IMCR D 1.31%
NRIX B 1.31%
RXRX D 1.31%
ERAS B 1.31%
GERN D 1.28%
CGEM F 1.27%
MRSN D 1.26%
TSVT C 1.25%
RCUS D 1.25%
BCYC C 1.24%
ZNTL F 1.23%
BNTX D 1.23%
LYEL F 1.23%
SDGR D 1.23%
FHTX C 1.22%
AUTL D 1.19%
MRK F 1.18%
LEGN F 1.18%
SWTX F 1.17%
GMAB F 1.16%
ACET F 1.14%
IPHA F 1.13%
TYRA F 1.11%
PGEN D 1.11%
KURA F 1.1%
VOR F 1.09%
NUVL D 1.08%
IDYA F 1.06%
NUVB D 1.02%
IMTX F 1.0%
ITOS F 0.99%
RLAY F 0.98%
IMRX F 0.89%
SMMT C 0.88%
FATE F 0.84%
PRLD F 0.65%
CNCR Underweight 53 Positions Relative to HTEC
Symbol Grade Weight
ILMN A -2.04%
AXGN D -1.97%
NTRA C -1.88%
ISRG A -1.87%
PEN C -1.87%
INCY A -1.86%
VRTX B -1.83%
RVTY C -1.79%
SYK B -1.76%
BSX B -1.75%
CRL D -1.72%
GH C -1.7%
CRSP C -1.7%
IRTC C -1.69%
VCYT B -1.65%
DHR F -1.61%
AORT B -1.6%
STAA F -1.59%
MASI B -1.58%
TMO F -1.57%
EXAS F -1.57%
CTLT D -1.54%
TWST C -1.53%
A C -1.49%
BIO B -1.48%
EW F -1.48%
ARWR D -1.46%
IART C -1.46%
OMCL B -1.45%
ABT C -1.45%
QGEN C -1.45%
NVCR C -1.42%
AZTA F -1.41%
MEDP D -1.39%
NOVT B -1.38%
GEHC D -1.38%
IQV F -1.37%
UTHR A -1.36%
ALGN F -1.31%
FLGT C -1.3%
GKOS B -1.29%
BDX F -1.27%
GMED B -1.26%
HOLX D -1.25%
DXCM F -1.24%
MRNA F -1.2%
CNMD C -1.14%
CDNA D -1.1%
VEEV B -1.1%
HCAT C -0.96%
BAX F -0.95%
BMRN F -0.93%
ALNY C -0.92%
Compare ETFs